← Signal Board

ORCHESTRA BIOMED HOLDINGS financial statements

오케스트라 바이오메드 홀딩스NASDAQ:OBIO · Nasdaq · Healthcare · sector #17
$5.66-3.08%
2026-10-07 close

ORCHESTRA BIOMED HOLDINGS's published financial data is dated 2026-10-04. 2024 revenue was $3M. 2024 operating profit was −$64M.

Reported results

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -13.57
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-13.57
Beneish M-Score
-3.40

No statistical flag

Sloan accrual
-13.74%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

2/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score2/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -1917%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업이익률 악화 (-1907.9% → -2437.5%, -529.6%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-2,437.5%
Interest coverage
-19.6x
Return on equity (ROE)
-185.2%

Operating margin −5pp

Operating loss
Interest coverageBase -19.6x adverse case -19.7x
Return on equity (ROE)Base -185.2% adverse case -205.4%

Revenue −15%

Interest coverage risk
Interest coverageBase -19.6x adverse case -16.7x
Return on equity (ROE)Base -185.2% adverse case -175.8%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -19.6x adverse case -15.5x
Return on equity (ROE)Base -185.2% adverse case -207.7%

Interest coverage limit

Already below the limit by 2,561.7pp

Interest coverage limit at an operating margin of 124.2%

Interest expense coverage threshold

ORCHESTRA BIOMED HOLDINGS notifications

Quantus Signal · live data · not investment advice · Privacy Policy